2 recruiting, 1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Hepatitis B, Chronic (CHB): new trials by email Literature Review of Hepatitis B, Chronic (CHB) trials Research Report on Hepatitis B, Chronic (CHB)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of AHB-171 in Chronic Hepatitis B Participants AHB-171 Injection - Hepatitis B, Chronic (CHB) | Phase 2 | Recruiting | Ausper Biopharma Co., Ltd. | 138 | 2026-06-24 | 2026-07-21 |
| Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study Peg IFN-α-2b - Hepatitis B, Chronic (CHB), Hepatitis B | Recruiting | First Affiliated Hospital Xi'an Jiaotong University | 1500 | 2025-01-01 | 2025-07-22 | |
| PegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (P04498/MK-4031-278) Pegylated interferon alfa-2b (PegIntron), Adefovir dipivoxil (adefovir) - Hepatitis B, Chronic (CHB) | Phase 3 | Completed | Merck Sharp & Dohme LLC | 25 | 2006-09-01 | 2017-04-06 |
Bronchiolitis Obliterans Syndrome (3) · Hepatitis B (3) · Carcinoma, Hepatocellular (1) · Fibrosis (1)
Blood-Borne Infections (3) · Bronchial Diseases (3) · Bronchiolitis (3) · Bronchiolitis Obliterans (3) · Bronchitis (3) · Communicable Diseases (3) · DNA Virus Infections (3) · Digestive System Diseases (3) · Graft vs Host Disease (3) · Hepadnaviridae Infections (3) · Hepatitis (3) · Hepatitis, Viral, Human (3) · Immune System Diseases (3) · Infections (3) · Liver Diseases (3)
adefovir dipivoxil (1) · peginterferon alfa-2b (1)
Ausper Biopharma Co., Ltd. (1) · First Affiliated Hospital Xi'an Jiaotong University (1) · Merck Sharp & Dohme LLC (1)
China (2)